Biotech · Private company
Advanced Accelerator Applications
Track this companyFree. Adds Advanced Accelerator Applications to your Dealase workspace and tells you when its record changes.
Clinical trials125 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- 177Lu-DOTA0-Tyr3-OctreotatePhase 3 · Carcinoid Tumor of the Small BowelClinicalTrials.gov · fetched Nov 12, 2026
- 2.5% Lys-Arg sterile amino acid solutionPhase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
- 30 mg Octreotide long acting repeatable (LAR) (Sandostatin LAR Depot)Phase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
- High dose 60 mg octreotide long-acting repeatablePhase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
- LutatheraPhase 3 · Gastro-enteropancreatic Neuroendocrine TumorClinicalTrials.gov · fetched Nov 12, 2026
- Octreotide LARPhase 3 · Carcinoid Tumor of the Small BowelClinicalTrials.gov · fetched Nov 12, 2026
- [177Lu]-NeoBPhase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- [68Ga]-NeoBPhase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- [68Ga]-PSMA-R2Phase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- LCZ696Phase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Lutetium [177Lu] oxodotreotide/dotatatePhase 2 · Gastroenteropancreatic Neuroendocrine TumorsClinicalTrials.gov · fetched Nov 12, 2026
- rhAnnexin V-128Phase 2 · SpondyloarthritisClinicalTrials.gov · fetched Nov 12, 2026
- 177Lu-PSMA-R2Phase 1 · Prostatic NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- LUTATHERANeuroendocrine TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast CancerPHASE2 · RECRUITING · started Jun 30, 2026ClinicalTrials.gov NCT04529044 · fetched Nov 12, 2026
- Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 28, 2022ClinicalTrials.gov NCT05249114 · fetched Nov 12, 2026
- Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLsPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 31, 2022ClinicalTrials.gov NCT04711135 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NETPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 8, 2020ClinicalTrials.gov NCT03972488 · fetched Nov 12, 2026
- Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI TractCOMPLETED · started Sep 25, 2019ClinicalTrials.gov NCT04069299 · fetched Nov 12, 2026
- [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion UptakePHASE1_PHASE2 · COMPLETED · started Jul 24, 2019ClinicalTrials.gov NCT03872778 · fetched Nov 12, 2026
- PET Imaging in Patients With Suspected Cardiac SarcoidosisCOMPLETED · started Dec 1, 2018ClinicalTrials.gov NCT03746847 · fetched Nov 12, 2026
- Post-Authorization Long-Term Safety Study of LUTATHERAACTIVE_NOT_RECRUITING · started Nov 28, 2018ClinicalTrials.gov NCT03691064 · fetched Nov 12, 2026
- 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerPHASE1 · TERMINATED · started May 24, 2018ClinicalTrials.gov NCT03490838 · fetched Nov 12, 2026
- 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)PHASE1_PHASE2 · COMPLETED · started May 23, 2018ClinicalTrials.gov NCT03490032 · fetched Nov 12, 2026
- 99mTc-rhAnnexin V-128 in Diagnosis of SpondyloarthritisPHASE2 · TERMINATED · started Sep 18, 2017ClinicalTrials.gov NCT03232580 · fetched Nov 12, 2026
- A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid TumoursPHASE3 · COMPLETED · started Sep 6, 2012ClinicalTrials.gov NCT01578239 · fetched Nov 12, 2026